MiNK Therapeutics (INKT) Change in Accured Expenses (2020 - 2026)
MiNK Therapeutics' Change in Accured Expenses was -$245,884 in Q2 2026, compared with -$16,891 a year earlier.
Powered by 
Analysis
MiNK Therapeutics (INKT) Change in Accured Expenses (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, MiNK Therapeutics' Change in Accured Expenses was $596,294 through Jun 30, 2026; for FY2025, it came in at $720,196.
- In earlier years, Change in Accured Expenses was -$393,771 in FY2024, $2.03 million in FY2023 (-40.9%), $3.42 million in FY2022 and -$72,607 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Change in Accured Expenses since Q4 2024.
- The best year-over-year quarter for Change in Accured Expenses over five years was Q1 2022 (growth of 713.6%); the worst was Q3 2022 (a decline of 99.4%).
- Per Business Quant data, INKT's Change in Accured Expenses in the three quarters before Q2 2026 was $206,262 (Q1 2026), $583,257 (Q4 2025) and $52,659 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | MiNK Therapeutics | 63.40 Mn | 63.40 Mn | - | -245,884.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -245,884.00 |
| Mar 31, 2026 | 206,262.00 |
| Dec 31, 2025 | 583,257.00 |
| Sep 30, 2025 | 52,659.00 |
| Jun 30, 2025 | -16,891.00 |
| Mar 31, 2025 | 101,171.00 |
| Dec 31, 2024 | -784,295.00 |
| Sep 30, 2024 | 345,665.00 |
| Jun 30, 2024 | -279,592.00 |
| Mar 31, 2024 | 324,451.00 |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | -390,839.00 |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | -549,527.00 |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 3,764.00 |
| Jun 30, 2022 | 367,322.00 |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | -1.30 Mn |
| Sep 30, 2021 | 642,286.00 |
API Access
MiNK Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "INKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();